SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001683168-21-000156
Filing Date
2021-01-14
Accepted
2021-01-14 16:03:00
Documents
35
Period of Report
2020-11-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q cannabics_10q-113020.htm 10-Q 296380
2 CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER cannabics_ex3101.htm EX-31.1 9944
3 CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER cannabics_ex3102.htm EX-31.2 9947
4 CERTIFICATION cannabics_ex3201.htm EX-32.1 4777
5 CERTIFICATION cannabics_ex3202.htm EX-32.2 4634
6 GRAPHIC image_001.jpg GRAPHIC 16314
7 GRAPHIC image_002.jpg GRAPHIC 7714
8 GRAPHIC image_003.jpg GRAPHIC 22758
  Complete submission text file 0001683168-21-000156.txt   1083231

Data Files

Seq Description Document Type Size
9 XBRL INSTANCE FILE cnbx-20201130.xml EX-101.INS 67552
10 XBRL SCHEMA FILE cnbx-20201130.xsd EX-101.SCH 10978
11 XBRL CALCULATION FILE cnbx-20201130_cal.xml EX-101.CAL 25060
12 XBRL DEFINITION FILE cnbx-20201130_def.xml EX-101.DEF 14963
13 XBRL LABEL FILE cnbx-20201130_lab.xml EX-101.LAB 99778
14 XBRL PRESENTATION FILE cnbx-20201130_pre.xml EX-101.PRE 71826
Mailing Address #3 BETHESDA METRO CENTER SUITE 700 BETHESDA MD 20814
Business Address #3 BETHESDA METRO CENTER SUITE 700 BETHESDA MD 20814 877-424-2429
Cannabics Pharmaceuticals Inc. (Filer) CIK: 0001343009 (see all company filings)

IRS No.: 203373669 | State of Incorp.: NV | Fiscal Year End: 0831
Type: 10-Q | Act: 34 | File No.: 000-52403 | Film No.: 21528762
SIC: 2834 Pharmaceutical Preparations